Medical specialists from Canada tagged as investigators in clinical trials studying Mental Disorders
Total 58 results
-
Addo Boafo, MDSeen in:
- Ontario, Ottawa, CHEO Research Institute
Trials:- NCT04369690 (Principal Investigator)
Conditions: -
Alasdair M Barr, Ph.D.Seen in:
- British Columbia, Vancouver, BC Mental Health & Addictions Research Institute
- British Columbia, Vancouver, BC Mental Health and Addictions Research Institute
- British Columbia, Vancouver, University of British Columbia Hospital - BC Psychosis Program
Trials:- NCT02322918 (Principal Investigator)
- NCT02009969 (Principal Investigator)
- NCT01966588 (Principal Investigator)
-
Alexander Daros, PhD, CPsychSeen in:
- Ontario, Ottawa, The Centre for Addiction and Mental Health
Trials:- NCT04369690 (Sub-Investigator)
Conditions: -
Alexandre Dumais, MD, PhDSeen in:
- Quebec, Montreal, Research center of the Institut universitaire en santé mentale de Montréal
- Quebec, Montréal, Centre de recherche de l'Institut universitaire en santé mentale de Montréal
Trials:- NCT04054778 (Principal Investigator)
- NCT05704582 (Principal Investigator)
-
Alissa Pencer, Ph.D.Seen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
Trials:- NCT06410508 (Sub-Investigator)
-
Angela Jerath, MD,FRCPCSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT04289142 (Sub-Investigator)
Conditions:- Mental Disorders;
- Nervous System Diseases;
- Neurologic Manifestations;
- Delirium;
- Confusion;
- Neurobehavioral Manifestations;
- Neurocognitive Disorders;
- Cognitive Dysfunction;
- Dexmedetomidine;
- Molecular Mechanisms of Pharmacological Action;
- Signs and Symptoms;
- Physiological Effects of Drugs;
- Analgesics, Non-Narcotic;
- Cognition Disorder;
- Central Nervous System Depressants;
- Analgesics;
- Hypnotics and Sedatives
-
Beverley A Orser, MD,PhD,FRCPCSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT04289142 (Sub-Investigator)
Conditions:- Mental Disorders;
- Nervous System Diseases;
- Neurologic Manifestations;
- Delirium;
- Confusion;
- Neurobehavioral Manifestations;
- Neurocognitive Disorders;
- Cognitive Dysfunction;
- Dexmedetomidine;
- Molecular Mechanisms of Pharmacological Action;
- Signs and Symptoms;
- Physiological Effects of Drugs;
- Analgesics, Non-Narcotic;
- Cognition Disorder;
- Central Nervous System Depressants;
- Analgesics;
- Hypnotics and Sedatives
-
Brannon Senger, MPHSeen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
Trials:- NCT06410508 (Sub-Investigator)
-
Brittany Chisholm, BSWSeen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
Trials:- NCT06410508 (Sub-Investigator)
-
Bruno J Losier, Ph.D.Seen in:
- Ontario, Hamilton, St. Joseph's Healthcare Hamilton
Trials:- NCT01708200 (Principal Investigator)
Conditions: -
Candice Crocker, Ph.D.Seen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
Trials:- NCT06410508 (Sub-Investigator)
-
Cynda Rushton, RN, PhDSeen in:
- Ontario, Ottawa, The Ottawa Hospital Research Institute
Trials:- NCT04369690 (Sub-Investigator)
Conditions: -
David Mazer, MD,FRCPC,PhDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT04289142 (Sub-Investigator)
Conditions:- Mental Disorders;
- Nervous System Diseases;
- Neurologic Manifestations;
- Delirium;
- Confusion;
- Neurobehavioral Manifestations;
- Neurocognitive Disorders;
- Cognitive Dysfunction;
- Dexmedetomidine;
- Molecular Mechanisms of Pharmacological Action;
- Signs and Symptoms;
- Physiological Effects of Drugs;
- Analgesics, Non-Narcotic;
- Cognition Disorder;
- Central Nervous System Depressants;
- Analgesics;
- Hypnotics and Sedatives
-
Denis Lafortune, PhDSeen in:
- Quebec, Montréal, University of Montreal
Trials:- NCT04369690 (Principal Investigator)
Conditions: -
Edward Spilg, FRCP, MScSeen in:
- Ontario, Ottawa, The Ottawa Hospital Research Institute
Trials:- NCT04369690 (Sub-Investigator)
Conditions: -
Eliza Garland, MSCSeen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
Trials:- NCT06410508 (Sub-Investigator)
-
Elizaveta Solomonova, PhDSeen in:
- Quebec, Montréal, McGill University
Trials:- NCT04369690 (Sub-Investigator)
Conditions: -
George Djaiani, MD,FRCPCSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT04289142 (Sub-Investigator)
Conditions:- Mental Disorders;
- Nervous System Diseases;
- Neurologic Manifestations;
- Delirium;
- Confusion;
- Neurobehavioral Manifestations;
- Neurocognitive Disorders;
- Cognitive Dysfunction;
- Dexmedetomidine;
- Molecular Mechanisms of Pharmacological Action;
- Signs and Symptoms;
- Physiological Effects of Drugs;
- Analgesics, Non-Narcotic;
- Cognition Disorder;
- Central Nervous System Depressants;
- Analgesics;
- Hypnotics and Sedatives
-
Ghassan El-Baalbaki, PhDSeen in:
- Quebec, Verdun, Douglas Research Center
Trials:- NCT05100875 (Sub-Investigator)
Conditions: -
Janet Jeffrey, RN, PhDSeen in:
- Ontario, Newmarket, Southlake Regional Health Centre
Trials:- NCT04369690 (Principal Investigator)
Conditions: -
Jason Morrison, MDSeen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memorial Building
Trials:- NCT04546178 (Sub-Investigator)
- NCT06410508 (Sub-Investigator)
-
Jean Addington, Ph.D.Seen in:
- Alberta, Calgary, University of Calgary
- Ontario, Toronto, Centre for Addiction and Mental Health
Trials:- NCT04338152 (Principal Investigator)
- NCT00722163 (Principal Investigator)
Conditions: -
Jean M Addington, PhDSeen in:
- Alberta, Calgary, Mathison Centre for Research and Education, University of Calgary
Trials:- NCT04829292 (Principal Investigator)
Conditions: -
Jennifer Phillips, PhDSeen in:
- Ontario, Ottawa, The Royal's Institute of Mental Health Research
Trials:- NCT04369690 (Sub-Investigator)
Conditions: -
Jodi Edwards, PhDSeen in:
- Ontario, Ottawa, The University of Ottawa Heart Institute
Trials:- NCT04369690 (Principal Investigator)
Conditions: -
Kara Dempster, MDSeen in:
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP)
- Nova Scotia, Halifax, Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memorial Building
Trials:- NCT04546178 (Sub-Investigator)
- NCT06410508 (Sub-Investigator)
-
Lena Quilty, PhD, CPsychSeen in:
- Ontario, Ottawa, The Centre for Addiction and Mental Health
Trials:- NCT04369690 (Principal Investigator)
Conditions: -
Leslie E Roos, PhDSeen in:
- Manitoba, Winnipeg, University of Manitoba - Department of Psychology
Trials:- NCT05959538 (Principal Investigator)
-
Mamta Gautam, FRCP MBASeen in:
- Ontario, Ottawa, The Ottawa Hospital Research Institute
Trials:- NCT04369690 (Sub-Investigator)
Conditions:
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown